Jobs
View more job listings or post a job
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Applied BioMath Technical Marketing Specialist
Horizon Therapeutics Director, Bioanalytical Sciences
Exelixis Principal Scientist - DMPK
Post a job


Position:
Scientist, DMPK

Employer:
Denali Therapeutics

Description:

Denali Therapeutics is seeking to hire a Scientist, DMPK, with expertise in drug discovery and early development. Working in collaboration with colleagues in Therapeutic Discovery, Development Sciences, and Clinical Development, the incumbent will help identify and advance lead drug candidates based on contributions related to biotransformation, metabolism enzymology, and pharmacokinetics. The role requires experience and expertise in drug metabolism, and involves execution of hypothesis-driven experiments using high-resolution mass spectrometry instrumentation, interpretation of complex data, and effective communication of results to cross-functional project teams.  The successful candidate will be a key DMPK contributor, with broad impact across a growing organization.

Responsibilities

  • Engage Biologists, Chemists, Toxicologists, and the DMPK team to work collectively enabling the advancement of the small molecule and biotherapeutic portfolio
  • Apply expertise in drug metabolism to design and conduct studies, and interpret data to assess biotransformation, metabolism enzymology, bioactivation, and metabolism kinetics to guide project teams at stages of drug discovery, preclinical and clinical development
  • Integrate data from metabolism studies with in silico, in vitro, PK, PK/PD, toxicology, and clinical data sets to understand in vitro-in vivo correlation, pharmacologically active metabolites, translation to humans, and risk assessment
  • Partner with Toxicology to assess relative metabolite exposures in preclinical species and humans for addressing metabolites in safety testing
  • Analyze, interpret, summarize and present DMPK data to internal project teams and senior management as a subject matter expert
  • Work with external laboratories to further develop biotransformation capability; review/QC data and engage CROs to enhance support of internal programs
  • Contribute to writing internal reports and Non-Clinical Pharmacology sections of regulatory (IND/CTA) filings


Qualifications/Experience:
  • PhD in Drug Metabolism, Pharmacokinetics, Chemistry or related scientific discipline with 0-3 years of biotech/pharmaceutical drug discovery and development experience; or BS/MS with 6-10 years of experience
  • Expertise in small molecule metabolite identification/structure elucidation and hepatic enzymology required
  • Knowledgeable, ideally with hands-on experience, in areas of bioanalysis, in vitro-in vivo translation, drug-drug interaction, or drug transport
  • Hands-on experience operating, troubleshooting, and maintaining LC-MS instruments; in particular, method development and high-resolution mass spectrometry to analyze drug and drug metabolites in biological matrices required
  • Excellent critical thinking and scientific skills, with a demonstrated ability to generate, interpret, and communicate complex DMPK data
  • Demonstrated ability to work effectively and collaboratively with other scientists on cross-functional projects teams
  • Excellent oral presentation and written communication skills


Location: South San Francisco, CA

Contact: Apply online: https://boards.greenhouse.io/dnli/jobs/2333344

Post Date: 1/21/2021 12:00:00 AM
©Pharmaceutical & BioScience Society, International; Last Modified: 4/24/2024; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Lena Biosciences Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
Lena Biosciences Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Submit a Text Ad